Search research articles
Contact Us
Filters
Showing results (141-150 of 177) with videos related to
Page
of 18
Sort By:
Molecular Plant-Microbe Interactions : MPMI
|
October 10, 2008
The C-terminal half of the HrpN virulence protein of the fire blight pathogen Erwinia amylovora is essential for its secretion and for its virulence and avirulence activities
Judith P Sinn, Chang-Sik Oh, Philip J Jensen, et al.
Journal of Bacteriology
|
March 20, 2019
Extragenic Suppression of Elongation Factor P Gene Mutant Phenotypes in Erwinia amylovora
Sara M Klee, Judith P Sinn, Aleah C Holmes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
J Heil, H M Kuerer, A Pfob, et al.
Molecular Plant Pathology
|
December 13, 2017
An Erwinia amylovora yjeK mutant exhibits reduced virulence, increased chemical sensitivity and numerous environmentally dependent proteomic alterations
Sara M Klee, Islam Mostafa, Sixue Chen, et al.
Molecular Plant Pathology
|
August 5, 2022
Putative transcription antiterminator RfaH contributes to Erwinia amylovora virulence
Sara M Klee, Judith P Sinn, Jeremy Held, et al.
Intensive Care Medicine
|
November 1, 1996
Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat
J Schmidt, K Huch, K Mithöfer, et al.
International Journal of Cancer
|
March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
T Schilling, J Bürck, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2010
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
A Schneeweiss, F Marmé, A Ruiz, et al.
Phytopathology
|
May 15, 2010
Virulence characteristics accounting for fire blight disease severity in apple trees and seedlings
Steven A Lee, Henry K Ngugi, Noemi O Halbrendt, et al.
International Journal of Cancer
|
June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients
A Seute, H P Sinn, R F Schlenk, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 177) with videos related to
Sort By:
Page
of 18
Molecular Plant-Microbe Interactions : MPMI
|
October 10, 2008
The C-terminal half of the HrpN virulence protein of the fire blight pathogen Erwinia amylovora is essential for its secretion and for its virulence and avirulence activities
Judith P Sinn, Chang-Sik Oh, Philip J Jensen, et al.
Journal of Bacteriology
|
March 20, 2019
Extragenic Suppression of Elongation Factor P Gene Mutant Phenotypes in Erwinia amylovora
Sara M Klee, Judith P Sinn, Aleah C Holmes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
J Heil, H M Kuerer, A Pfob, et al.
Molecular Plant Pathology
|
December 13, 2017
An Erwinia amylovora yjeK mutant exhibits reduced virulence, increased chemical sensitivity and numerous environmentally dependent proteomic alterations
Sara M Klee, Islam Mostafa, Sixue Chen, et al.
Molecular Plant Pathology
|
August 5, 2022
Putative transcription antiterminator RfaH contributes to Erwinia amylovora virulence
Sara M Klee, Judith P Sinn, Jeremy Held, et al.
Intensive Care Medicine
|
November 1, 1996
Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat
J Schmidt, K Huch, K Mithöfer, et al.
International Journal of Cancer
|
March 10, 2001
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
T Schilling, J Bürck, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 25, 2010
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
A Schneeweiss, F Marmé, A Ruiz, et al.
Phytopathology
|
May 15, 2010
Virulence characteristics accounting for fire blight disease severity in apple trees and seedlings
Steven A Lee, Henry K Ngugi, Noemi O Halbrendt, et al.
International Journal of Cancer
|
June 8, 2001
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients
A Seute, H P Sinn, R F Schlenk, et al.
Page
of 18